{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:13:02Z","timestamp":1790813582128,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100025799","name":"American Neuromuscular Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025799","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jneuroim.2024.578360","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T21:35:37Z","timestamp":1714944937000},"page":"578360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Immune dysregulation in chronic inflammatory demyelinating polyneuropathy"],"prefix":"10.1016","volume":"391","author":[{"given":"Yingkai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Guptill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vern C.","family":"Juel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hobson-Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti M.","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabitha","family":"Karatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karissa L.","family":"Gable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2024.578360_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/cei.12215","article-title":"CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy","volume":"175","author":"Abraham","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0010","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.27709","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy","volume":"66","author":"Allen","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0020","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jamaneurol.2020.0781","article-title":"Monitoring clinical course and treatment response in chronic inflammatory demyelinating polyneuropathy during routine care: a review of clinical and laboratory assessment measures","volume":"77","author":"Allen","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0030","first-page":"5649","article-title":"Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice","volume":"175","author":"Bour-Jordan","year":"2005","journal-title":"J. Immunol. (Baltimore, Md\u202f: 1950)"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0035","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/mus.25198","article-title":"International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r","volume":"54","author":"Burns","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1529-8027.2008.00158.x","article-title":"Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"13","author":"Chi","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR gamma t directs the differentiation program of proinflammatory IL-17(+) T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.expneurol.2018.11.006","article-title":"Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients","volume":"312","author":"Li","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.66.5.677","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south East England","volume":"66","author":"Lunn","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00684474","article-title":"Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study","volume":"18","author":"Prineas","year":"1971","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/nmt-2019-0009","article-title":"Outcome measures for chronic inflammatory demyelinating polyneuropathy in research: relevance and applicability to clinical practice","volume":"9","author":"Rajabally","year":"2019","journal-title":"Neurodegen. Dis. Manag."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.194.5.677","article-title":"Development of spontaneous autoimmune peripheral polyneuropathy in B7-2\u2013deficient nod mice","volume":"194","author":"Salomon","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.0b013e318245d250","article-title":"CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Schneider-Hohendorf","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00005072-199756070-00008","article-title":"Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"56","author":"Shy","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0105","first-page":"1580","article-title":"IL-10 paradoxically promotes autoimmune neuropathy through S1PR1-dependent CD4(+) T cell migration","volume":"200","author":"Smith","year":"2018","journal-title":"J. Immunol. (Baltimore, Md\u202f: 1950)"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ilar\/ilt054","article-title":"Animal models of autoimmune neuropathy","volume":"54","author":"Soliven","year":"2014","journal-title":"ILAR J."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0115","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1212\/01.wnl.0000188879.19900.b7","article-title":"Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP","volume":"65","author":"Sommer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12883-017-0860-z","article-title":"Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP","volume":"17","author":"Staudt","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0125","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.4049\/jimmunol.1200493","article-title":"Defective autoimmune regulator-dependent central tolerance to myelin protein zero is linked to autoimmune peripheral neuropathy","volume":"188","author":"Su","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0130","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2024.578360_bb0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jns.12455","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"26","author":"Van den Bergh","year":"2021","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0140","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.nmd.2013.06.006","article-title":"196th ENMC international workshop: outcome measures in inflammatory peripheral neuropathies 8-10 February 2013, Naarden, the Netherlands","volume":"23","author":"Vanhoutte","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0145","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2015.00532","article-title":"Evidence from human and animal studies: pathological roles of CD8(+) T cells in autoimmune peripheral neuropathies","volume":"6","author":"Yang","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0150","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis","volume":"52","author":"Yi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113146","article-title":"Inhibition of the transcription factor ROR-\u03b3 reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis","volume":"325","author":"Yi","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578360_bb0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.expneurol.2008.11.014","article-title":"Distribution of Foxp3+ T-regulatory cells in experimental autoimmune neuritis rats","volume":"216","author":"Zhang","year":"2009","journal-title":"Exp. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282400078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282400078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T20:33:54Z","timestamp":1717619634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557282400078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"alternative-id":["S016557282400078X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578360","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune dysregulation in chronic inflammatory demyelinating polyneuropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578360"}}